Anallely Nguyen, Jing Wang, Daniel C. Ehlman, and Deborah M. Stone are with the Division of Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Kristin M. Holland is with the Division of Violence Prevention, National Center for Injury Prevention and Control, CDC. Laura E. Welder and Kimberly D. Miller are with the Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC.
Am J Public Health. 2024 Oct;114(10):1081-1085. doi: 10.2105/AJPH.2024.307745. Epub 2024 Aug 8.
To examine trends in overdose deaths by intent and drug category to better understand the recent decrease in overdose suicides amid the overdose epidemic. We examined trends in rates of overdose deaths by intent (unintentional, suicide, or undetermined) across 9 drug categories from 1999 to 2022 using US National Vital Statistics System mortality data. Unintentional overdoses involving synthetic opioids, polydrug toxicity involving synthetic opioids, psychostimulants, and cocaine increased exponentially with annual percentage changes ranging from 15.0% to 104.9% during 2010 to 2022. The death rates also increased for suicides involving these drugs, especially for psychostimulants (annual percentage change = 12.9% for 2010-2022; < .001). However, these drugs accounted for relatively small percentages of overdose suicides. The leading drug categories among suicides were antidepressants, prescription opioids, and benzodiazepines, though these deaths have decreased or leveled off in recent years. Different drugs commonly involved in suicides and unintentional overdoses may contribute to their divergent trends. Amid the overdose epidemic, safe storage of medications remains a crucial strategy to prevent overdose suicides. The large increases in suicides involving psychostimulants warrant monitoring. (. 2024;114(10):1081-1085. https://doi.org/10.2105/AJPH.2024.307745).
为了更好地了解在阿片类药物流行期间自杀性过量死亡最近减少的原因,我们研究了不同意图(非故意、自杀或不确定)和 9 种药物类别的过量死亡趋势。我们使用美国国家生命统计系统的死亡率数据,研究了 1999 年至 2022 年不同意图(非故意、自杀或不确定)和 9 种药物类别的过量死亡趋势。涉及合成阿片类药物、涉及合成阿片类药物、苯丙胺类兴奋剂和可卡因的非故意过量用药以及多药物毒性呈指数增长,2010 年至 2022 年期间的年百分比变化范围为 15.0%至 104.9%。这些药物的自杀死亡率也有所增加,特别是苯丙胺类兴奋剂(2010-2022 年的年百分比变化=12.9%;<.001)。然而,这些药物在过量自杀中只占相对较小的比例。自杀的主要药物类别是抗抑郁药、处方类阿片类药物和苯二氮䓬类药物,尽管近年来这些药物的死亡人数有所下降或趋于平稳。自杀和非故意过量用药中常见的不同药物可能导致它们的趋势不同。在阿片类药物流行期间,安全储存药物仍然是预防过量自杀的关键策略。涉及苯丙胺类兴奋剂的自杀人数大幅增加值得关注。(. 2024;114(10):1081-1085. https://doi.org/10.2105/AJPH.2024.307745)。